Korea Alternative Investment Asset Management
VC Fund
Korea Alternative Investment Asset Management is an investment firm.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Korea Alternative Investment Asset Management invests in
Stages Korea Alternative Investment Asset Management invests in
Countries Korea Alternative Investment Asset Management invests in
Round sizes
Round size
- Seed
- $797k–$16M
- Series A
- $1.6M–$16M
- Series B
- $2.4M–$13M
Investment Focus
Industry
- Health Care 4 (25%)
- Medical Device 3 (19%)
- Pharmaceutical 3 (19%)
- Apps 2 (13%)
- Cosmetics 2 (13%)
Stage
- Series A 8 (50%)
- Seed 2 (13%)
- Series B 2 (13%)
- Series C 2 (13%)
- Venture - Series Unknown 2 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ASWEMAKE
|
ASWEMAKE is a provider of digital transformation management solutions, dedicated to creating a customer experience that makes purchasing daily necessities online as satisfying as buying them in person. By focusing on developing online sales infrastructure within competitive nationwide food ingredient markets and collaborating with local offlinepartners, the company aims to achieve 'Today's Shopping,' where orders made today are delivered the same day throughout the country, leveraging logistics and distribution services. It operates 'Q Market,' an application for same-day delivery from local grocery stores. Q Market serves as an O2O service that links consumers residing within a 3km radius of medium-to-large offline supermarkets, using city center supermarkets as delivery hubs to ensure that orders reach customers' doorsteps on the same day. The company is committed to offering consumers a fresher 'Convenience Premium' (Convenience + Premium) by setting itself apart through the use of logistics warehouses associated with supermarkets, ensuring that the products customers require are delivered as quickly as possible. | Series C / Dec 22, 2025 | |
Best Innovation
|
Best Innovation is a manufacturer of cosmetic products intended to offer a safe alternative to harmful skincare chemicals. | $15.8M / Seed / Jan 15, 2025 | |
Kookmin Bio
|
Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials. | $2.4M / Series B / Nov 20, 2024 | |
VAXDIGM
|
VAXDIGM focuses on the development of advanced vaccines and future vaccines. | $2M / Series A / Oct 23, 2024 | |
Leesol
|
Leesol is a sleep technology company engaged in the production of AI based neuromodulation devices for the prevention and treatment solutions for modern-day people’s healthy brains. The company's product range includes the sleepisol which is a functional smart wearable device that utilizes CES (Cranial Electrotherapy Stimulation) and is aneffective product for the customer’s quality of sleep and life. The product can also be used with a user-oriented data based App. | $3M / Series A / Oct 02, 2024 | |
LSBIO
|
LS Bio is a specialized corporation that conducts research, develops, and produces high-functional health foods, food and medicine materials, and Medifood (a compound term of medicine and food) to address a super-aging civilization in the century-old age. We want to develop bio-natural medicines in the future utilizing raw materials approved by theMinistry of Food and Drug Safety and active ingredients derived from natural sources. | $797.1K / Seed / Jun 07, 2024 | |
NextPay
|
NextPay provides payment infrastructure including online and offline payment systems. | $3.1M / Series A / May 24, 2024 | |
Vinssen
|
Vinssen is a manufacturer of electric and hydrogen ships. | $15.4M / Series C / Dec 01, 2023 | |
Plating
|
Plating provides healthy and delicious food is the best welfare. Plating releases new products every week and has presented about 50 menus to our customers so far. | $2.4M / Series A / Jun 30, 2023 | |
|
Kookmin Bio
|
Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials. | $1.6M / Series A / May 19, 2022 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Korea Alternative Investment Asset Management invest in?
Korea Alternative Investment Asset Management invests primarily in Health Care, Medical Device and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 16 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Korea Alternative Investment Asset Management's check size?
Korea Alternative Investment Asset Management typically joins rounds of $797k–$16M at Seed, $1.6M–$16M at Series A and $2.4M–$13M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Korea Alternative Investment Asset Management participates in.
When did Korea Alternative Investment Asset Management last invest?
The most recent investment recorded for Korea Alternative Investment Asset Management closed in Dec 2025. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
